| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |